Fig. 6: Linking hallmark activity to drug response and clinical outcomes.

Heatmaps show the impact of various anticancer drugs on hallmark activity, alongside their associations with (a) disease-free survival, b progression-free survival, and c overall survival. Darker shades correspond to stronger drug–hallmark interactions, revealing key therapeutic contributions to improved patient outcomes.